New to The Street Interview with Nicole Sandford, CEO

Aspira’s CEO, Nicole Sandford, talked with Jane King of New to The Street about ovarian cancer and how Aspira is advancing ovarian cancer risk assessment with advanced bioinformatics and noninvasive blood tests.